Omnicell to Release Third Quarter 2023 Financial Results on November 2, 2023
16 Outubro 2023 - 5:01PM
Business Wire
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication
management solutions and adherence tools for healthcare systems and
pharmacies, will release its financial results for the third
quarter 2023, before market open on Thursday, November 2, 2023. The
Company will host a conference call and webcast to discuss its
financial results at 8:30 a.m. ET that same day.
All interested parties are invited to listen to the live call
and presentation by dialing (888) 550-5424 in the U.S. or (646)
960-0819 in international locations. The Conference ID is
9581556.
A link to the live and archived webcast will also be available
on the Investor Relations section of Omnicell’s website at
https://ir.omnicell.com/events-and-presentations/.
About Omnicell
Since 1992, Omnicell has been committed to transforming the
pharmacy care delivery model in an effort to optimize financial and
clinical outcomes across all settings of care. Through a
comprehensive portfolio of automation and advanced services,
Omnicell is uniquely positioned to address evolving healthcare
challenges, connect settings of care, and streamline the medication
management process. Healthcare facilities worldwide partner with
Omnicell to help increase operational efficiency, reduce medication
errors, improve patient safety, and enhance patient engagement and
adherence, helping to reduce costly hospital readmissions. To learn
more, visit omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of
Omnicell, Inc. or one of its subsidiaries.
OMCL-E
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231016582653/en/
Kathleen Nemeth Senior Vice President, Investor Relations
ir@omnicell.com
Omnicell (NASDAQ:OMCL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Omnicell (NASDAQ:OMCL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024